PerkinElmer has launched the Signals Research Suite, a secure informatics platform deployed on Amazon Web Services which provides scientific data and workflow management for pharmaceutical and industrial customers.
Designed to help drive more informed and accelerated decision-making around drug, compound and formulation candidates, the offering brings together PerkinElmer’s informatics technologies across data access, processing, enhanced analytics, and collaboration.
Leveraging the suite, multi-discipline R&D teams can unify critical experiment and testing data, better configure and control their workflows, and easily manage critical scientific results.
Commenting on the research suite, Kevin Willoe, Vice President and General Manager of PerkinElmer Informatics, said: “Today’s pharmaceutical and industrial companies are moving towards digital transformation and away from managing scientific data in silos. They want to focus on doing better science, reduce their dependence on managing IT systems, and interact with their data globally from end-to-end.
“Our secure, SaaS Signals Research Suite offering allows them to do this, empowering them to harness their data and collaborate with their colleagues and partners to make better, faster, and more precise candidate choices.”